Brief total synthesis of the cell cycle inhibitor tryprostatin B and related preparation of its alanine analogue

Journal of Organic Chemistry

Volumn 68, Issue 18, 2003, Pages 6944-6951

  Caballero, Esmeralda ^a   Avendaño, Carmen ^a   Menéndez, J Carlos ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE INHIBITOR;

CATALYSIS; CELLS; SYNTHESIS (CHEMICAL);

ORGANIC COMPOUNDS;

ACID ANHYDRIDE; ALANINE DERIVATIVE; ALKALOID; INDOLE DERIVATIVE; PRENYLAMINE; TRYPROSTATIN B; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; PRENYLATION;

ALANINE; ANTIBIOTICS, ANTINEOPLASTIC; ASPERGILLUS; CATALYSIS; CELL CYCLE; CYCLIZATION; HYDROLYSIS; INDICATORS AND REAGENTS; INDOLE ALKALOIDS; INDOLES; MASS SPECTROMETRY; MOLECULAR CONFORMATION; PIPERAZINES; STEREOISOMERISM;

EID: 0042338580     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo034703l     Document Type: Article

References (61)

1. Crews, C. M.; Mohan, R. Curr. Opin. Chem. Biol. 2000, 4, 47-53.
2. Osada, H. Jpn. J. Cancer Chemother. 1997, 24, 1541-1546.
3. Osada, H. J. Antibiotics 1998, 51, 973-982.
4. (a) Cui, C.; Kakeya, H.; Okada, G.; Onose, R.; Ubukata, M.; Takahashi, I.; Isono, K.; Osada, H. J. Antibiot. 1995, 48, 1382-1384.
5. (b) Cui, C.; Kakeya, H.; Okada, G.; Onose, R.; Osada, H. J. Antibiot. 1996, 49, 527-533.
6. (c) Cui, C.; Kakeya, H.; Osada, H. J. Antibiot. 1996, 49, 534-540.
7. (a) Birch, A. J.; Blance, G. E.; David, S.; Smith, H. J. Chem. Soc. 1961, 3128.
8. (b) Takamatsu, N.; Inoue, S.; Kishi, Y. Tetrahedron Lett. 1971, 4657-4660 and 4665-4668.
9. (a) Dossena, A.; Marchelli, R.; Pochini, A. J. Chem. Soc., Chem. Commun. 1974, 771-772.
10. (b) Plate, R.; Nivard, R. J. F.; Ottenheijm, H. C. J. Chem. Soc., Perkin Trans. 1 1987, 2473-2480.
11. Steyn, P. S. Tetrahedron Lett. 1971, 3331-3334.
12. Steyn, P. S. Tetrahedron 1973, 21, 107-120.
13. (a) Kondoh, M.; Usui, T.; Mayumi, T., Osada, H. J. Antibiot. 1998, 51, 801-804.
14. (b) Usui, T.; Kondoh, M.; Cui, C.-B.; Mayumi, T.; Osada, H. Biochem. J. 1998, 333, 543-548.
15. Kanoh, K.; Kohno, S.; Ashari, T.; Harada, T.; Katada, J.; Muramatsu, M.; Kawashima, H.; Sekiya, H.; Uno, I. Bioorg. Med. Chem. Lett. 1997, 7, 2847-2852.
16. Cui, C. B.; Kakeya; Osada, H. Tetrahedron 1996, 52, 12651-12666.
17. Cui, C. B.; Kakeya; Osada, H. Tetrahedron 1997, 53, 59-72.
18. Usui, T.; Kondoh, M.; Cui, C.; Mayumi, T.; Osada, H. Biochem. J. 1998, 333, 543-548.
19. (a) Zhao, S.; Smith, K. S.; Deveau, A. M.; Dieckhaus, C. M.; Johnson, M. A.; Macdonald, T. L.; Cook, J. M. J. Med. Chem. 2002, 45, 1559-1562.
20. For additional work on the biological activity of tryprostatin analogues, see: (b) Sanz-Cervera, J. F.; Stocking, E. M.; Usui, T.; Osada, H.; Williams, R. M. Bioorg. Med. Chem. 2000, 8, 2407-2415.
21. (c) Wang, H.; Usui, T.; Ganessan, A. J. Med. Chem. 2000, 43, 1577-1585.
22. (a) Depew, K. M.; Danishefsky, S. J.; Rosen, N.; Sepp-Lorenzino, L. J. Am. Chem. Soc. 1996, 118, 12463-12464.
23. (b) Schkeryantz, J. M.; Woo, J. C. G.; Siliphaivanh, P.; Depew, K. M.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11964-11975.
24. (a) Gan, T.; Cook, J. M. Tetrahedron Lett. 1997, 38, 1301-1304.
25. (b) Gan, T.; Liu, R.; Yu, P.; Zhao, S.; Cook, J. M. J. Org. Chem. 1997, 62, 9298-9304.
26. (c) Zhao, S.; Gan, T.; Yu, P.; Cook, J. M. Tetrahedron Lett. 1998, 39, 7009-7012.
27. (d) Ma, C.; Liu, X.; Li, X.; Flippen-Anderson, J.; Yu, S.; Cook, J. M. J. Org. Chem. 2001, 66, 4525-4542.
28. Zhao, S.; Gan, T.; Cook, J. M. Tetrahedron Lett. 1998, 39, 7009-7012.
29. (a) Cardoso, A. S.; Lobo, A. M.; Prabhakar, S. Tetrahedron Lett. 2000, 41, 3611-3613.
30. (b) Lobo, A. M.; Prabhakar, S. J. Heterocycl. Chem. 2002, 39, 429-436.
31. Wang, B.; Chen, L.; Kim, K. Tetrahedron Lett. 2001, 42, 1463-1466.
32. For precedent ofprenyl migration from C-3 to C-2 triggered by ring opening in related systems, see: (a) Nakagawa, N. M.; Matsuki, K.; Hasumi, K.; Taniguchi, M.; Hino, T. Heterocycles 1982, 19, 156 (symposium abstract). (b) Hino, T.; Hasumi, K.; Yamaguchi, H.; Taniguchi, M.; Nakagawa, M. Chem. Pharm. Bull. 1985, 33, 5202-5206. (c) Plate, R.; Ottenheijm, H. C. J. Tetrahedron Lett. 1986, 27, 3755-3758.
33. For precedent ofprenyl migration from C-3 to C-2 triggered by ring opening in related systems, see: (a) Nakagawa, N. M.; Matsuki, K.; Hasumi, K.; Taniguchi, M.; Hino, T. Heterocycles 1982, 19, 156 (symposium abstract). (b) Hino, T.; Hasumi, K.; Yamaguchi, H.; Taniguchi, M.; Nakagawa, M. Chem. Pharm. Bull. 1985, 33, 5202-5206. (c) Plate, R.; Ottenheijm, H. C. J. Tetrahedron Lett. 1986, 27, 3755-3758.
34. For precedent ofprenyl migration from C-3 to C-2 triggered by ring opening in related systems, see: (a) Nakagawa, N. M.; Matsuki, K.; Hasumi, K.; Taniguchi, M.; Hino, T. Heterocycles 1982, 19, 156 (symposium abstract). (b) Hino, T.; Hasumi, K.; Yamaguchi, H.; Taniguchi, M.; Nakagawa, M. Chem. Pharm. Bull. 1985, 33, 5202-5206. (c) Plate, R.; Ottenheijm, H. C. J. Tetrahedron Lett. 1986, 27, 3755-3758.
35. Bruncko, M.; Crich, D.; Samy, R. J. Org. Chem. 1994, 59, 5543-5549.
36. Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron 1999, 55, 14185-14198.
37. (a) For a review of the chemistry of cyclic tautomers of tryptophan and tryptamines, see: Hino, T.; Nakagawa, M. In The Alkaloids; Brossi, A., Ed.; 1988; Vol. 34, pp 1-75.
38. See also. (b) Crich, D.; Natarajan, S. J. Org. Chem. 1995, 60, 6237-6241 and references therein.
39. See ref 23a, and also: (a) Sammes, P. G.; Weedon, A. C. J. Chem. Soc., Perkin Trans. 1 1979, 3048-3052. (b) Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron: Asymmetry 1998, 9, 967-981. (c) Taniguchi, M.; Yamamoto, I.; Nakagawa, M.; Hino, T. Chem. Pharm. Bull. 1985, 33, 4783-4791.
40. See ref 23a, and also: (a) Sammes, P. G.; Weedon, A. C. J. Chem. Soc., Perkin Trans. 1 1979, 3048-3052. (b) Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron: Asymmetry 1998, 9, 967-981. (c) Taniguchi, M.; Yamamoto, I.; Nakagawa, M.; Hino, T. Chem. Pharm. Bull. 1985, 33, 4783-4791.
41. See ref 23a, and also: (a) Sammes, P. G.; Weedon, A. C. J. Chem. Soc., Perkin Trans. 1 1979, 3048-3052. (b) Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron: Asymmetry 1998, 9, 967-981. (c) Taniguchi, M.; Yamamoto, I.; Nakagawa, M.; Hino, T. Chem. Pharm. Bull. 1985, 33, 4783-4791.
42. (a) Muthusubramanian, P.; Carlé, J. S.; Christophersen, C. Acta Chem. Scand. B 1983, 37, 803-807.
43. (b) Mitchell, M. O.; Le Quesne, P. W. Tetrahedron Lett. 1990, 31, 2681-2684.
44. (c) Mitchell, M. O.; Dorroh, P. Tetrahedron Lett. 1991, 32, 7641-7642.
45. Bocchi, V.; Casnati, G.; Marchelli, R. Tetrahedron 1978, 34, 929-932.
46. Compound 3 has been prepared from N-Cbz-L-prolyl-L-tryptophan methyl ester (ref 8). Our procedure employing the N-Boc derivative is more convenient and can be found in Supporting Information.
47. Prenyl iodide used in this experiment was prepared in 71% yield from prenyl alcohol and Olah's chlorotrimethylsilane/sodium iodide reagent. See: Olah, G. A.; Narang, S. B.; Gupta, B.; Malhotra, R. J. Org. Chem. 1979, 44, 1247-1251.
48. (a) Joule, J. A.; Mills, K.; Smith, G. F. Heterocyclic Chemistry, 3rd ed.; Chapman & Hall: New York, 1995; p 303.
49. (b) Casnati, G.; Dossena, A.; Pochini, A. Tetrahedron Lett. 1972, 5277-5280.
50. Molander, G. A.; Harris, C. R. In Encyclopedia of Reagents for Organic Synthesis; Paquette, L. A., Ed.; John Wiley and Sons: New York, 1995; Vol. 8, pp 5522-5523.
51. Sharma, G. V. M.; Ilangovan, A.; Mahalingam, A. K. J. Org. Chem. 1998, 63, 9103-9104.
52. For a review of the biosynthesis of prenylated alkaloids derived from tryptophan, see: Williams, R. M.; Stocking, E. M.; Sanz-Cervera, J. F. Top. Curr. Chem. 2000, 209, 98-173.
53. (a) Casnati, G.; Marchelli, R.; Pochini, A. J. Chem. Soc., Perkin Trans. 1 1974, 754-757.
54. (b) Inada, S.; Nagai, K.; Takayanagi, Y.; Okazaki, M. Bull. Chem. Soc. Jpn. 1976, 49, 833-834.
55. (c) Sammes, P. G.; Weedon, A. C. J. Chem. Soc., Perkin Trans. 1 1979, 3053-3059.
56. (d) Grundon, M. F.; Hamblin, M. R.; Harrison, D. M.; Logue, J. N. D.; Maguire, M.; McGrath, J. A. J. Chem. Soc., Perkin Trans. 1 1980, 1294-1298.
57. (e) See also ref 18.
58. 3, 63 MHz): δ 168.1; 166.0; 147.5; 135.5; 132.8; 128.4; 123.0; 119.3; 118.9; 109.4; 80.9; 60.7; 59.8; 56.2; 45.2; 38.7; 35.4; 27.8; 26.1; 23.3; 18.1.
59. 3): δ -76.00 (s).
60. 3): δ -76.1 (s).
61. Compound 10 has been isolated from natural sources. See, for instance: Hamasaki, T.; Nagayama, K.; Hatsuda, Y. Agric. Biol. Chem. 1976, 40, 2487. For its preparation, see ref 24b.